1. Home
  2. News
  3. Immutep Ltd
  4. INSIGHT-003 investigator-initiated trial - 1st patient dosed
More Immutep Ltd news
Immutep LtdASX: IMM

INSIGHT-003 investigator-initiated trial - 1st patient dosed

Aug 4, 2021 at 10:40 PM EDT · Issued by Immutep Ltd

Filed with ASX · Aug 4, 2021 at 10:40 PM EDT · 2 pages · English

On 6ix: 6ix.com/news/insight-003-investigator-initiated-trial-1st-patient-dosed

Immutep Ltd on 6ix

Earlier from Immutep

  • Completion of Placement - Tranche 2Jul 29, 2021
  • Completion of Share Purchase PlanJul 20, 2021
  • US FDA & IRB approves start of ph2b head & neck cancer trialJul 5, 2021
  • Efti to be evaluated in new triple combination therapy trialJun 21, 2021
  • Immutep secures commitments for A$60 million in a PlacementJun 20, 2021

Later from Immutep

  • Chinese patent granted for anti-LAG-3 antibody LAG525Aug 26, 2021
  • Immuteps partner, EOC Pharma, expands efti trial pipelineAug 30, 2021
  • Recruitment of patients completed for Part B of TACTI-002Sep 1, 2021
  • Immutep Receives A$3.4 million R&D French Tax IncentiveSep 28, 2021
  • Immutep Quarterly Activities Report & Appendix 4COct 27, 2021
All Immutep news releases↗

Follow Immutep into a list and get an email when it puts out news.

Follow Immutep
  • About 6ix
  • Editorial & Sourcing
  • Corrections
  • Contact
  • Privacy
  • Terms
  • Disclaimer